# AE-941 in Treating Patients With Metastatic Kidney Cancer

> **NCT00005995** · PHASE3 · COMPLETED · sponsor: **AEterna Zentaris**

## Conditions studied

- Kidney Cancer

## Interventions

- **DRUG:** shark cartilage extract AE-941

## Key facts

- **NCT ID:** NCT00005995
- **Lead sponsor:** AEterna Zentaris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** 2007-03
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005995, "AE-941 in Treating Patients With Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00005995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*